Lion TCR

OverviewSuggest Edit

Lion TCR is a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases. The Company's lead product targets hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).

HQSingapore, SG

Latest Updates

Cybersecurity ratingAMore

Key People/Management at Lion TCR

Lietao Li

Lietao Li

Founder, CEO
Antonio Bertoletti

Antonio Bertoletti

Scientific Founder
Stephen Lim

Stephen Lim

Show more

Lion TCR Office Locations

Lion TCR has offices in Singapore and Guangzhou
Singapore, SG (HQ)
61 Biopolis Dr
Singapore, SG
2 Tukang Innovation Grove, 09
Show all (3)

Lion TCR Financials and Metrics

Summary Metrics

Lion TCR total Funding

$20 m

Lion TCR latest funding size

$20 m

Time since last funding

2 years ago

Lion TCR investors

Lion TCR's latest funding round in May 2018 was reported to be $20 m. In total, Lion TCR has raised $20 m
Show all financial metrics

Lion TCR Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Lion TCR Online and Social Media Presence

Embed Graph

Lion TCR Blogs

Lion TCR receives US$ 20 million to fund its personalized T cell therapy clinical trials against Liver cancer

May 27, 2018 – Lion TCR Pte Ltd, a clinical stage biotech pioneering T cell therapy against viral- related cancer, announced today they have raised US$ 20 million in its Series A financing...
Show more

Lion TCR Frequently Asked Questions

  • Who are Lion TCR key executives?

    Lion TCR's key executives are Lietao Li, Antonio Bertoletti and Stephen Lim.

  • Who are Lion TCR competitors?

    Competitors of Lion TCR include Agenus, Viralytics and Tetherex.

  • Where is Lion TCR headquarters?

    Lion TCR headquarters is located at 61 Biopolis Dr, Singapore.

  • Where are Lion TCR offices?

    Lion TCR has offices in Singapore and Guangzhou.

  • How many offices does Lion TCR have?

    Lion TCR has 3 offices.